EPISODE · May 5, 2026 · 1 MIN
IART Earnings: Stabilizing or Stumbling?
from The Daily News Now! Business
Integra LifeSciences (IART) releases Q1 earnings, expected to show flat revenue, a slowdown from last years growth. The medical device company has struggled with inconsistent performance, missing revenue targets several times. Despite this, IARTs stock has risen 17.1% in the last month, trading around $10.91, with an average price target of $15.67. Investors will watch for guidance on stability in this competitive sector. Support the show:Get a discount at https://solipillow.com/discount/dnn. Advertise on DNN:[email protected] This is an automated, high-level news summary based on public reporting.Report issues to [email protected]. View sources & latest updates:https://sources.thednn.ai/c06f045be23c6c53
NOW PLAYING
IART Earnings: Stabilizing or Stumbling?
No transcript for this episode yet
Similar Episodes
Mar 26, 2026 ·1m
Mar 19, 2026 ·34m
Feb 18, 2026 ·11m
Feb 11, 2026 ·45m